Calendar

2012 Inhalation and Nasal Technology Focus Group (INTFG) Annual Fall Symposium: Excipients for Pulmonary Delivery—Challenges and Opportunities

Catherine Abbott — Fri, 18 May 2012 15:11:17 GMT

2012 Inhalation and Nasal Technology Focus Group (INTFG) Annual Fall Symposium: Excipients for Pulmonary Delivery—Challenges and Opportunities 2012-09-07 2012-09-07 This one day symposium will feature the latest advances in the development of excipients for orally inhaled and nasal drug prod

Webinar: Particle Characterization Techniques—Part 2: Analytical Techniques for Nasal & Inhalation Technologies

Catherine Abbott — Wed, 16 May 2012 14:50:25 GMT

Webinar: Particle Characterization Techniques—Part 2: Analytical Techniques for Nasal & Inhalation Technologies 2012-06-14 12:30 PM 2012-06-14 2:00 PM Andrew Parker, M.D. Molecular Profiles Ltd., UK This presentation will draw upon some diverse recent case studies from the literature in the

Solubility Criteria for Veterinary Products(2)

Catherine Abbott — Wed, 16 May 2012 14:38:08 GMT

Solubility Criteria for Veterinary Products 2012-11-07 2012-11-08 The USP Expert Panel (EP) for Veterinary Products is evaluating the criteria for considering drugs as “fully soluble” when orally administered to veterinary species. The industry recognizes that, given the diverse gastro-intes

Fifth World Conference on Drug Absorption, Transport and Delivery: Responding to Challenging Situations

Catherine Abbott — Mon, 14 May 2012 17:26:41 GMT

Fifth World Conference on Drug Absorption, Transport and Delivery: Responding to Challenging Situations 2012-06-24 2012-06-26 The objective of this conference is to present the latest progress in understanding of drug absorption mechanisms, to consider the importance of drug transporters, an

The Direction for Healthcare Education and Pharmacy

Catherine Abbott — Mon, 14 May 2012 17:27:18 GMT

The Direction for Healthcare Education and Pharmacy 2012-06-19 12:00 PM 2012-06-19 4:30 PM Sir Christopher Edwards, Rosalynne Cheeseman and Susan Sanders This half day Education Colloquium event will be free to RPS members, offering an overview of the current landscape of pharmacy education. We

Time to Event Analysis for Pharmacokineticists

Catherine Abbott — Mon, 14 May 2012 17:27:38 GMT

Time to Event Analysis for Pharmacokineticists 2012-07-26 3:30 PM 2012-07-26 5:00 PM Nick Holford University of Auckland, New Zealand After PK came PKPD then disease progression. What’s next? The ability to predict clinical events like death, dropout, fracture, and stroke is missing from clinica

NIPTE Research Conference

Catherine Abbott — Mon, 14 May 2012 17:28:14 GMT

NIPTE Research Conference Understanding Exceipient Performance - Key to Successful QbD Formulation Design 2012-06-13 2012-06-14 NIPTE has received several contracts and a U01 Grant for research from the U.S. Food and Drug Administration (FDA) to conduct research in pharmaceutical technology

The Freeze Drying of Pharmaceuticals and Biologicals Conference

Catherine Abbott — Wed, 02 May 2012 16:41:19 GMT

The Freeze Drying of Pharmaceuticals and Biologicals Conference 2012-08-07 2012-08-10 This international symposium will begin with an informal welcome reception on Tuesday, August 7 at 6:30 pm and will end at 2:45 pm, Friday, August 10. Invited podium presentations focused on both formulatio

Advances in Clinical Biomarkers and Diagnostics: Discovery, Development and Regulation

Catherine Abbott — Wed, 02 May 2012 16:40:05 GMT

Advances in Clinical Biomarkers and Diagnostics: Discovery, Development and Regulation 2012-09-24 2012-09-25 This workshop will be an extension of the 2009 AAPS Biomarker Workshop. A key goal of this workshop is to publish a white paper or a meeting report. The 2009 AAPS Biomarker Workshop p

Tabletting Technology for the Pharmaceutical Industry

Catherine Abbott — Tue, 01 May 2012 18:19:26 GMT

Tabletting Technology for the Pharmaceutical Industry 2012-11-19 2012-11-21 Do you work in formulation development or the production of tablets? Do you require an intensive course of study on the formulation, production, and drug-release characteristics of pharmaceutical tablets? This up-to-

AAPS-NRPB Biomarker Workshop

Catherine Abbott — Tue, 24 Apr 2012 17:51:55 GMT

AAPS-NRPB Biomarker Workshop 2012-09-24 2012-09-25 This workshop will be an extension of the 2009 AAPS Biomarker Workshop. It will provide a dialogue opportunity and educational highlights of biomarkers applications in drug development and disease diagnosis as well as treatment. A key goal o

Drug Product Development: A QbD Approach

Catherine Abbott — Thu, 19 Apr 2012 18:31:40 GMT

Drug Product Development: A QbD Approach 2012-06-12 2012-06-12 This workshop will provide a scientific, systematic, but also practical approach for the development and review of drug products, called Quality-by-Design (QbD). Non-AAPS Meeting Faculty of Pharmacy, University of Toronto,

Webinar: Optimizing Oral Exposure in Drug Discovery: Role of Physicochemical and DMPK Properties

Catherine Abbott — Tue, 03 Apr 2012 17:49:03 GMT

Webinar: Optimizing Oral Exposure in Drug Discovery: Role of Physicochemical and DMPK Properties 2012-06-07 12:30 PM 2012-06-07 2:00 PM Sachin Lohani, Ph.D., and Karen H. Dingley, Ph.D. Merck & Co. This webinar will go through the theory and use case studies to illustrate the role of formula

PQRI Workshop on Application of IVIVC in Formulation Development

Catherine Abbott — Tue, 27 Mar 2012 14:18:38 GMT

PQRI Workshop on Application of IVIVC in Formulation Development 2012-09-05 2012-09-06 In vitro in vivo correlation (IVIVC) is an important concept and a tool in the development and evaluation of pharmaceutical dosage forms, especially modified release dosage forms. The workshop will review

AAPS Workshop on Predicting and Monitoring Impurities in API and Drug Products: Product Development and Regulatory Issues

Catherine Abbott — Mon, 26 Mar 2012 19:46:27 GMT

AAPS Workshop on Predicting and Monitoring Impurities in API and Drug Products: Product Development and Regulatory Issues 2012-10-13 2012-10-14 Predicting and monitoring impurities in Active Pharmaceutical Ingredient (API) and drug products challenge process and product development from ear

AAPS Workshop on Oral Bioperformance and 21st Century Testing

Catherine Abbott — Mon, 26 Mar 2012 14:25:25 GMT

AAPS Workshop on Oral Bioperformance and 21st Century Testing 2012-10-13 2012-10-14 Dissolution testing, while fundamentally important as the critical link between efficacy and the manufactured oral dosage form, has not changed substantially since it was introduced and standardized in Pharm

Fifth Annual Nanotechnology and Nanomedicine Symposium

Catherine Abbott — Tue, 13 Mar 2012 12:49:42 GMT

Fifth Annual Nanotechnology and Nanomedicine Symposium 2012-09-21 2012-09-22 Nanotechnology is a rapidly growing industry, incorporating all fields of science and similar studies. The theme, "Nano is Too Big," is intended to entice curious persons to dive deeper into the field of nanotechno

Challenges in Dissolution Workshop

Catherine Abbott — Fri, 02 Mar 2012 14:46:08 GMT

Challenges in Dissolution Workshop 2012-06-11 2012-06-12 A discussion of issues associated with dissolution of pharmaceutical dosage forms—such as semisolid dosage forms applied to the skin, liquid-filled capsules, and gelatin capsules—and of other products, such as botanicals and dietary su

Microbiological Control of Compendial Articles: A Workshop on Current Status and Future Directions of Compendial Standards

Catherine Abbott — Fri, 02 Mar 2012 14:44:44 GMT

Microbiological Control of Compendial Articles: A Workshop on Current Status and Future Directions of Compendial Standards 2012-07-23 2012-07-24 The workshop portion of this open discussion will present information on current USP Microbiology Expert Committee chapters and potential and draft

5th Workshop on the Characterization of Heparin Products

Catherine Abbott — Thu, 01 Mar 2012 20:22:43 GMT

5th Workshop on the Characterization of Heparin Products 2012-08-14 2012-08-15 An informal workshop intended to encourage open discussion and debate on the physico-chemical and functional characterization of therapeutic products derived from heparin and to explore possible clinical and regul